← Back to headlines
Intelligent Bio Solutions Clears Accuracy Milestone Ahead of FDA Submission
The biotech firm reports achieving over 98% accuracy in method comparison testing, positioning it to proceed with a planned 2026 FDA 510(k) regulatory submission for its diagnostic platform.
1 Sept, 12:31 — 1 Sept, 12:31
